Multiple Synthetic Routes to the Mini-Protein Omomyc and Coiled-Coil Domain Truncations-Reference-Cited by-同舟云学术

Multiple Synthetic Routes to the Mini-Protein Omomyc and Coiled-Coil Domain Truncations

Published:2019-10-29 Issue:3 Volume:85 Page:1466-1475
ISSN:0022-3263
Container-title:The Journal of Organic Chemistry
language:en
Short-container-title:J. Org. Chem.

Author:

Brown Zachary Z.¹,Mapelli Claudio¹^ORCID,Farasat Iman²,Shoultz Alycia V.²,Johnson Scott A.³,Orvieto Federica⁴,Santoprete Alessia⁴,Bianchi Elisabetta⁴,McCracken Amy Bittner¹,Chen Kuanchang¹,Zhu Xiaohong¹,Demma Mark J.⁵,Lacey Brian M.⁶,Canada Keith A.²,Garbaccio Robert M.¹,O’Neil Jennifer⁵,Walji Abbas¹

Affiliation:

1. Discovery Chemistry, Merck & Co., Inc., 2000 Galloping Hill Road, Kenilworth, New Jersey 07033, United States

2. Protein Engineering, Merck & Co., Inc., 126 East Lincoln Avenue, Rahway, New Jersey 07065, United States

3. Discovery Chemistry, Merck & Co., 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States

4. Peptide Chemistry, IRBM, SpA, Via Pontina km 30 600, 00071 Pomezia (RM), Italy

5. Oncology Discovery, Merck & Co., Inc. 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States

6. Pharmacology, Merck & Co., Inc., 33 Avenue Louis Pasteur, Boston, Massachusetts 02115, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.joc.9b02467

Reference21 articles.

1. MYC—Master Regulator of the Cancer Epigenome and Transcriptome

2. Strategies to Inhibit Myc and Their Clinical Applicability

3. Reflecting on 25 years with MYC

4. Targeting oncogenic Myc as a strategy for cancer treatment

5. OmoMYC blunts promoter invasion by oncogenic MYC to inhibit gene expression characteristic of MYC-dependent tumors

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic Peptides: Promising Modalities for the Targeting of Disease‐Related Nucleic Acids;Angewandte Chemie International Edition;2024-04-09

2. Synthetic Peptides: Promising Modalities for the Targeting of Disease‐Related Nucleic Acids;Angewandte Chemie;2024-04-09

3. Development of DuoMYC: a synthetic cell penetrant miniprotein that efficiently inhibits the oncogenic transcription factor MYC;2024-03-08

4. MYC the oncogene from hell: Novel opportunities for cancer therapy;European Journal of Medicinal Chemistry;2024-03

5. Discovery and characterization of anti-cancer peptides from a random peptide library;PLOS ONE;2024-02-13